Prevalence of ocular surface disease in patients with glaucoma using topical antiglaucoma medications

F Barisic, K Novak Laus, R Iveković, I Krolo… - Journal of clinical & …, 2014 - croris.hr
F Barisic, K Novak Laus, R Iveković, I Krolo, S Popovic Suic, I Sesar, M Simic Prskalo…
Journal of clinical & experimental ophthalmology, 2014croris.hr
Purpose: To establish the prevalence of ocular surface disease (OSD) in glaucoma patients
using topical intraocular pressure-lowering (IOP) therapy and to compare the frequency and
severity of symptoms with the control group of normal subjects. Methods: This prospective,
multicenter, observational study included patients with glaucoma in four different
Departments of Ophthalmology. A matched group of normal subjects served as controls. For
each patient we have collected detailed family history, clinical records and calculated ocular …
Purpose
To establish the prevalence of ocular surface disease (OSD) in glaucoma patients using topical intraocular pressure-lowering (IOP) therapy and to compare the frequency and severity of symptoms with the control group of normal subjects.
Methods
This prospective, multicenter, observational study included patients with glaucoma in four different Departments of Ophthalmology. A matched group of normal subjects served as controls. For each patient we have collected detailed family history, clinical records and calculated ocular surface disease index (OSDI) scores (0-100), based on the information obtained from OSDI questionnaires.
Results
In total, we have evaluated 160 patients. Of those, 110 were glaucoma patients and 50 were normal subjects. Among 110 glaucoma treated patients 83 (75%) had OSDI scores indicating mild to severe OSD. Among 50 patients without glaucoma 15 (30%) had OSDI score indicating mostly mild to moderate OSD. The severity of symptoms correlates with the number of IOP medications used and the duration of treatment.
Conclusion
This study confirms the high prevalence of OSD in patients treated for glaucoma with topical IOP medications. The adverse effect of these agents can influence the compliance and successful treatment of glaucoma patients.
croris.hr
以上显示的是最相近的搜索结果。 查看全部搜索结果